000 05346nam a22005535i 4500
999 _c200457524
_d75736
003 DE-He213
005 20231109085816.0
007 cr nn 008mamaa
008 220801s2022 sz | s |||| 0|eng d
020 _a9783030972202
024 7 _a10.1007/978-3-030-97220-2
_2doi
040 _aTR-AnTOB
_beng
_erda
_cTR-AnTOB
060 _aWN 250
072 7 _aMMN
_2bicssc
072 7 _aMED080000
_2bisacsh
072 7 _aMKR
_2thema
096 _aWN250EBK
245 1 0 _aRadionuclide Therapy
_h[electronic resource] /
_cedited by Recep Bekiş, Berna Polack, Murat Fani Bozkurt.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart-1: Basic Information. Basic properties and preparation of radiopharmaceuticals used in radionuclide therapy -- Physical Bases of Radionuclide Therapy (Biological Effects and Properties of Particle Radiation) -- Fundamentals of radiation safety and dosimetric approach in radionuclide therapy applications. Part-2: Clinical Information: Thyroid Diseases. Radionuclide Therapy in Benign Thyroid Diseases: Nodular Goiter Disease -- Radionuclide Therapy in Benign Thyroid Diseases: Graves' Disease -- Radionuclide Therapy in Malignant Thyroid Diseases: Differentiated Thyroid Cancer -- Radionuclide Therapy in Malignant Thyroid Diseases: Medullary Thyroid Cancer -- Systemic Treatments and related side effects in Thyroid Cancer. Part-2: Clinical Information: Neuroendocrine Tumors. Radionuclide Therapy in Neuroendocrine Tumors. Systemic Treatments and related side effects in Neuroendocrine Tumors. Part-4: Clinical Information: Neuroectodermal Tumors. Radionuclide Therapy in Neuroectodermal Tumors -- Systemic Treatments and related side effects in Neuroectodermal Tumors. Part-5: Clinical Information: Liver Tumors. Radionuclide Therapy in Liver Tumors. Systemic Treatments and related side effects in Liver Tumors. Part-6: Clinical Information: Prostate Cancer. Radionuclide Therapy in Prostate Cancer -- Systemic Treatments and related side effects in Prostate Cancer. Part-7: Clinical Information: Bone and Joint Diseases. Radionuclide Therapy in Joint Diseases: Radiosynovectomy -- Radionuclide Pain Palliation Therapy -- Radionuclide Therapy with Alpha Emitting Agents in Bone Metastases. Part-8: Clinical Information: Lymphoproliferative Diseases. Radionuclide Therapy in Lymphoproliferative Diseases. Part-9: Radioimmunotherapy. Basics and clinical applications of radioimmunotherapy. Part-10: Intracavitary Radionuclide Therapy. Intracavitary radionuclide applications.
520 _aThe main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments. Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted treatments, personalized treatments, external beam radiotherapy, and targeted radionuclide treatments have begun to take their place in professional practice. Nuclear medicine, in addition to its role as a tracer of cancer, also assumes the role of treating with radioactive molecules directed to the cancer it traces. These traceable next-generation radionuclide treatments, whose efficacy and reliability have been proven and where diagnosis, treatment, and follow-up are carried out together, are increasingly included in oncology practice together with the new developed radiopharmaceuticals, ensuring a high rate of damage to cancer cells while protecting the surrounding normal tissues. Molecular cancer treatment will become more effective with individualized next-generation traceable radionuclide treatments, which will be shaped by genetic studies in the future. Radionuclide treatments for many cancer types and benign diseases are presented by experienced nuclear medicine experts in the light of their own experience and case studies, while systemic treatments in common cancer types and side effect management of these treatments are summarized by medical oncologists. This book will be of interest to nuclear medicine physicians as well as oncologists.
650 0 _aNuclear medicine.
650 0 _aOncology.
650 0 _aEndocrinology.
650 0 _aGastroenterology.
650 1 4 _aNuclear Medicine.
650 2 4 _aOncology.
650 2 4 _aEndocrinology.
650 2 4 _aGastroenterology.
653 0 _aRadiotherapy
653 0 _aNuclear Medicine
700 1 _aBekiş, Recep.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aPolack, Berna.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBozkurt, Murat Fani.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-030-97220-2
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng